JNNP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lundberg, P. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lundberg, P. O.
Related Collections
Right arrow New Variant Creutzfeld-Jakob Disease/BSE/Mad Cow Disease
Right arrow Other Neurology
Right arrow Barker Hypothesis
J Neurol Neurosurg Psychiatry 1998;65:836-841 ( December )

Creutzfeldt-Jakob disease in Sweden

Per Olov Lundberg

Department of Neuroscience, Neurology, Uppsala University, University Hospital, SE 751 85 Uppsala, Sweden

Correspondence to: Professor P O Lundberg, Department of Neuroscience, Neurology, Uppsala University, University Hospital, SE 751 85 Uppsala, Sweden. Telephone and fax 0046 18 66 50 26; email PO.Lundberg{at}neurologi.uu.se

Received 2 April 1998; Accepted 29 May 1998

OBJECTIVES---To find and investigate, retrospectively, as many cases as possible of Creutzfeldt-Jakob disease (CJD) in Sweden dying during the period 1 January 1985 to 31 December 1996 and to detect any possible case(s) of new variant CJD.
METHODS---The patients were found through computer search of all death certificates in Sweden on which CJD was mentioned, through information from the Swedish neuropathologists, and spontaneous reports from Swedish doctors and hospitals. Data concerning the patients were then collected from patients' case records and from brain histopathology reports.
RESULTS---In total 72 cases of spongiform encephalopathy were confirmed as definite by neuropathology, one of them with Gerstmann-Stäussler-Scheinker disease. In 51 further cases there were no brain pathology data but the diagnosis "probable" (37 patients) or "possible" (14 patients) CJD according to WHO criteria could be made on clinical grounds. There was a variation in number of deaths/year, from a minimum of five (1985) to a maximum of 16 (1990). Sixty patients died during the period 1985-90 and 62 during 1991-6. The sex ratio was nearly 1:1. Calculated for a population of 8.6 million (mean of 12 years) in Sweden this gives 1.18/million/year. Age at the time of the presenting symptoms ranged from 34 to 84 years. Only one patient was under 40 at the onset of symptoms. He had a spongiform encephalopathy but prion protein staining was negative. The duration of symptoms that could be attributed to CJD was 6 months or less in 75 cases, 7-12 months in 16 cases, 1 to 2 years in 15 cases, and more than 2 years in 16 patients. By definition all patients were demented. Other more common symptoms and signs were aphasia, dysphasia, dysathria, ataxia, myoclonus, pareses of the extremities, rigidity or spasticity, different types of hyperkinesias, and other psychiatric symptoms (depression, anxiety, and aggressiveness). Less common symptoms were hallucinations (mainly visual), visual defects, sensory symptoms (paraesthesias, itching, or pain), apraxia of swallowing, and disorders of eye movements.
CONCLUSIONS---The incidence, the symptomatology, the age distribution (age in years at onset and at death), and the duration of illness were similar to those of other countries except for the cases of new variant CJD in the United Kingdom. There is so far no indication of any cases of new variant CJD in Sweden.

Keywords: Creutzfeldt-Jakob disease; prion disease; incidence; Sweden


© 1998 by Journal of Neurology, Neurosurgery, and Psychiatry



This article has been cited by other articles:


Home page
J. Neurol. Neurosurg. PsychiatryHome page
S A Cooper, K L Murray, C A Heath, R G Will, and R S G Knight
Sporadic Creutzfeldt-Jakob disease with cerebellar ataxia at onset in the UK
J. Neurol. Neurosurg. Psychiatry, November 1, 2006; 77(11): 1273 - 1275.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
A. Krasnianski, W. J. Schulz-Schaeffer, K. Kallenberg, B. Meissner, D. A. Collie, S. Roeber, M. Bartl, U. Heinemann, D. Varges, H. A. Kretzschmar, et al.
Clinical findings and diagnostic tests in the MV2 subtype of sporadic CJD
Brain, September 1, 2006; 129(9): 2288 - 2296.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
M. Pocchiari, M. Puopolo, E. A. Croes, H. Budka, E. Gelpi, S. Collins, V. Lewis, T. Sutcliffe, A. Guilivi, N. Delasnerie-Laupretre, et al.
Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies
Brain, October 1, 2004; 127(10): 2348 - 2359.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
C. E. M. Hillier and R. L. Salmon
Is there evidence for exogenous risk factors in the aetiology and spread of Creutzfeldt-Jakob disease?
QJM, September 1, 2000; 93(9): 617 - 631.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 1998 by the BMJ Publishing Group Ltd.